Lisata Therapeutics Statistics Share Statistics Lisata Therapeutics has 8.6M
shares outstanding. The number of shares has increased by 3.35%
in one year.
Shares Outstanding 8.6M Shares Change (YoY) 3.35% Shares Change (QoQ) -0.25% Owned by Institutions (%) 9.11% Shares Floating 6.84M Failed to Deliver (FTD) Shares 25,681 FTD / Avg. Volume 77.71%
Short Selling Information The latest short interest is 29.55K, so 0.34% of the outstanding
shares have been sold short.
Short Interest 29.55K Short % of Shares Out 0.34% Short % of Float 0.42% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.24 and the forward
PE ratio is -2.13.
Lisata Therapeutics's PEG ratio is
0.18.
PE Ratio -1.24 Forward PE -2.13 PS Ratio 24.82 Forward PS 43.1 PB Ratio 0.84 P/FCF Ratio -1.28 PEG Ratio 0.18
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Lisata Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.16,
with a Debt / Equity ratio of 0.
Current Ratio 6.16 Quick Ratio 6.16 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $38.46K Profits Per Employee $-768.65K Employee Count 26 Asset Turnover 0.03 Inventory Turnover n/a
Taxes Income Tax -798K Effective Tax Rate 3.84%
Stock Price Statistics The stock price has increased by -5.46% in the
last 52 weeks. The beta is 0.94, so Lisata Therapeutics's
price volatility has been higher than the market average.
Beta 0.94 52-Week Price Change -5.46% 50-Day Moving Average 2.63 200-Day Moving Average 2.64 Relative Strength Index (RSI) 48.09 Average Volume (20 Days) 33,048
Income Statement In the last 12 months, Lisata Therapeutics had revenue of 1M
and earned -19.98M
in profits. Earnings per share was -2.4.
Revenue 1M Gross Profit 826K Operating Income -22.41M Net Income -19.98M EBITDA -22.23M EBIT -22.41M Earnings Per Share (EPS) -2.4
Full Income Statement Balance Sheet The company has 16.21M in cash and 137K in
debt, giving a net cash position of 16.07M.
Cash & Cash Equivalents 16.21M Total Debt 137K Net Cash 16.07M Retained Earnings -548.07M Total Assets 28.98M Working Capital 24.81M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -19.36M
and capital expenditures 0, giving a free cash flow of -19.36M.
Operating Cash Flow -19.36M Capital Expenditures n/a Free Cash Flow -19.36M FCF Per Share -2.32
Full Cash Flow Statement Margins Gross margin is 82.6%, with operating and profit margins of -2240.9% and -1998.5%.
Gross Margin 82.6% Operating Margin -2240.9% Pretax Margin -2078.3% Profit Margin -1998.5% EBITDA Margin -2223.5% EBIT Margin -2240.9% FCF Margin -1935.6%
Dividends & Yields LSTA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for LSTA is $23.5,
which is 748.4% higher than the current price. The consensus rating is "Strong Buy".
Price Target $23.5 Price Target Difference 748.4% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 15, 2022. It was a
backward
split with a ratio of 1:15.
Last Split Date Sep 15, 2022 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -23.95 Piotroski F-Score 2
